EUS-Guided gallbladder drainage vs percutaneous transhepatic drainage in patients with acute cholecystitis: a systematic review and meta-analysis

医学 胆囊 经皮 科克伦图书馆 不利影响 胆囊炎 胆囊切除术 排水 急性胆囊炎 普通外科 系统回顾 荟萃分析 外科 梅德林 内科学 法学 政治学 生物 生态学
作者
Edson Guzmán‐Calderón,Alfonso Alfonso Chacaltana,Carlos Díaz-Arocutipa,Ramiro Dı́az,Ronald Arcana,José Ramón Aparicio
出处
期刊:Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru [Sociedad de Gastroenterologia del Peru]
卷期号:42 (3): 163-70 被引量:1
标识
DOI:10.47892/rgp.2022.423.1375
摘要

Occasionally, cholecystectomy is not possible because the patient is not suitable for surgery, and non-operative management should be performed. In these patients, the non-operative management can be through the percutaneous transhepatic gallbladder drainage (PTGBD) or the endoscopic gallbladder drainage. We decided to compare the efficacy and safety of PTGBD and EUS-GBD in the non-operative management of patients with acute cholecystitis. We conducted a systematic review in different databases, such as PubMed, OVID, Medline, and Cochrane Databases. This meta-analysis considers studies published until September 2021. Six studies were selected (2 RCTs). These studies included 749 patients. The mean age was 72.81 ±7.41 years, and males represented 57.4%. EUS-GBD technical success was lower than PTGBD (RR, 0.97; 95% CI, 0.95-0.99), whereas clinical success and adverse events rates were similar in both groups. Twenty-one deaths were reported in all six studies. The global mortality rate was 2.80%, without differences in both groups (2.84% and 2.77% in the EUS-GBD group and the PTGBD groups, respectively). EUS-GBD and PTGBD were successful techniques for gallbladder drainage in patients with acute cholecystitis who are non-tributary for surgery. EUS-GBD has a similar clinical success rate and a similar adverse events rate in comparison to PTGBD. The high technical success and the low adverse events rate of the EUS approach to gallbladder make this technique an excellent alternative for patients with acute cholecystitis who cannot be undergoing surgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
有梦想的人不睡觉完成签到,获得积分10
1秒前
1秒前
1秒前
2秒前
希望天下0贩的0应助Q11采纳,获得10
3秒前
怪蜀黍发布了新的文献求助10
5秒前
5秒前
在见君关注了科研通微信公众号
5秒前
安全网123发布了新的文献求助10
7秒前
lize5493发布了新的文献求助10
10秒前
10秒前
嗯哼举报FartKing求助涉嫌违规
11秒前
FJY发布了新的文献求助10
11秒前
一期一会完成签到,获得积分10
12秒前
852应助晓舟采纳,获得10
12秒前
Lighterx完成签到,获得积分10
16秒前
mnhkj发布了新的文献求助30
17秒前
童年的回忆klwqqt完成签到,获得积分10
19秒前
19秒前
思源应助lelelelelelele采纳,获得10
21秒前
搜集达人应助gaohigh采纳,获得10
23秒前
CodeCraft应助研友_Z34DG8采纳,获得10
24秒前
suzy-123发布了新的文献求助150
26秒前
丘比特应助子车半烟采纳,获得10
27秒前
orixero应助jkl1027采纳,获得10
27秒前
28秒前
28秒前
ding应助悲凉的半梦采纳,获得10
29秒前
嗯哼举报巧可脆脆求助涉嫌违规
32秒前
DL发布了新的文献求助10
34秒前
阿曼尼发布了新的文献求助10
34秒前
35秒前
35秒前
drk发布了新的文献求助10
36秒前
iii发布了新的文献求助30
36秒前
充电宝应助狐狐采纳,获得10
37秒前
在见君发布了新的文献求助10
37秒前
阳光代芙发布了新的文献求助30
38秒前
田様应助寒冷忆山采纳,获得10
39秒前
xcc发布了新的文献求助10
40秒前
高分求助中
Evolution 10000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 600
Distribution Dependent Stochastic Differential Equations 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3157301
求助须知:如何正确求助?哪些是违规求助? 2808735
关于积分的说明 7878261
捐赠科研通 2467077
什么是DOI,文献DOI怎么找? 1313197
科研通“疑难数据库(出版商)”最低求助积分说明 630369
版权声明 601919